Cardiac ATP-sensitive potassium channel (Cardiac KATP channel)

The cardiac ATP-sensitive potassium (KATP) channel is a hetero-octameric protein complex that serves as a critical metabolic sensor in the heart, coupling intracellular energy levels to membrane excitability (UniProt: P48048, O60706). It consists of four inward-rectifier potassium channel subunits (Kir6.2) and four regulatory sulfonylurea receptor subunits (SUR2A). Under normal physiological conditions, high intracellular ATP concentrations keep the channel closed; however, during metabolic stress such as myocardial ischemia or hypoxia, a decrease in the ATP/ADP ratio triggers channel opening (PubMed: 15133403). This leads to an efflux of potassium ions, causing membrane hyperpolarization and a significant shortening of the cardiac action potential duration (APD). This APD shortening reduces the time available for calcium entry through L-type calcium channels, thereby conserving ATP and protecting the myocardium from calcium overload and irreversible damage—a process central to ischemic preconditioning. Clinically, potassium channel openers like nicorandil are employed to treat angina pectoris by activating these channels, while non-selective sulfonylureas used for type 2 diabetes can block them, potentially impairing the heart's natural defense against ischemia (PubMed: 21551234, StatPearls: NBK526031).

Other names

KATP channelATP-sensitive inward rectifier potassium channelKir6.2/SUR2A complexKCNJ11/ABCC9 complexInward rectifier potassium channel 11

Potassium channel openers (KCOs) bind to the SUR2A subunit to increase the open-state probability of the channel, leading to potassium efflux and hyperpolarization. Conversely, sulfonylureas act as channel blockers by binding to the SUR subunits and inhibiting the pore-forming Kir6.2 subunits, thereby preventing potassium efflux and increasing cellular excitability.